Clinical Trials Directory

Trials / Completed

CompletedNCT03573284

Validity of Fractional Exhaled Nitric Oxide and Impulse Oscillometry in Patients With Cough Variant Asthma

Evaluating the Efficacy of Fractional Exhaled Nitric Oxide and Impulse Oscillometry in Patients With Cough Variant Asthma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
146 (actual)
Sponsor
Zhujiang Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of the research is to evaluate the clinical value of fractional exhaled nitric oxide(FeNO) ,impulse oscillometry(IOS) and mid-expiratory flow (MEF) in patients with cough variant asthma.

Detailed description

The present study has the following objectives: to evaluate the relationship between BHR and mid-expiratory flow, to assess the diagnostic accuracy of fractional exhaled nitric oxide,impulse oscillometry and mid-expiratory flow in CVA with special regard to its discriminating value between CVA and other causes of a chronic cough, to estimate prognostic value of BHR and fractional exhaled nitric oxide (FeNO) count in predicting response to asthma treatment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTfractional exhaled nitric oxide(FeNO)FeNO level was evaluated according to the American Thoracic Society (ATS)/ERS recommendations using a NIOX MINO analyzer (Aerocrine, Solna, Sweden) .Subjects were informed to deeply inhale NO-free air and immediately exhale in full via a mouthpiece at a constant flow rate (50 ml/s) for 10s.
DIAGNOSTIC_TESTimpulse oscillometry(IOS)The patient take seats, body relax, make sure the mouthpiece is fully covered by mouth, then clip nose with both hands to cover both sides of the cheek, and then calm breathing 1 minutes, the computer is automatically collected data calculation and print out the measurement results.

Timeline

Start date
2018-08-12
Primary completion
2019-06-30
Completion
2019-06-30
First posted
2018-06-29
Last updated
2021-07-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03573284. Inclusion in this directory is not an endorsement.